Skip to main content
. 2021 May 31;64(9):1927–1938. doi: 10.1007/s00125-021-05471-x

Fig. 3.

Fig. 3

Mean changes in body weight during TDR from baseline (visit 1, week 0) for the whole intervention group (n = 143) and for those who discontinued antihypertensive medications (n = 69). Numbers decline as participants move to FR or withdraw (TDR continued beyond 12 weeks for small numbers with poorer adherence, whose weight losses were smaller)